Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ranibizumab for Retinal Ganglion Cell Function in Diabetic Macular Edema
NCT02055911Phase 4Withdrawn
- Sponsor
- Federal University of São Paulo
- Start
- Mar 2014
- Primary completion
- Mar 2015
- Modality
- Antibody Fragments, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of ranibizumab in diabetic macular edema (DME), sponsored by Federal University of São Paulo. Planned start Mar 2014; status: withdrawn.
02
Drugs
ranibizumab
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT02055911.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02055911.